Science Explorer Interactive view Map
Company · Changzhou · China

LipidALL Technologies (China)

lipidall.comROR OpenAlex
Research works
17
▲ 771% vs 2013–17
Citations
636
37.8 per fractional work
Top-10% rate
56.9%
record average 16.5%
Open access
74%
world 28%

Not ranked overall: LipidALL Technologies (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.98× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.32× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.81× its world share, 0 worksImmunology and Micro…Neuroscience: 3.24× its world share, 0 worksNeuroscienceChemistry: 1.39× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.35× its world share, 0 worksEarth and Planetary …Environmental Science: 0.24× its world share, 0 worksEnvironmental ScienceMedicine: 1.71× its world share, 3 worksMedicineNursing: 4.63× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.3×. Every wedge is a field page.

Which research topics does LipidALL Technologies (China) publish most on?

By volume in 2022–2025: Metabolomics and Mass Spectrometry Studies, Reproductive Physiology in Livestock, Lipid metabolism and biosynthesis and Autophagy in Disease and Therapy.

Metabolomics and Mass Sp…1Metabolomics and Mass Spectrometry Studies: 1 fractional worksReproductive Physiology in Livestock: 0 fractional worksLipid metabolism and bio…0Lipid metabolism and biosynthesis: 0 fractional worksAutophagy in Disease and…0Autophagy in Disease and Therapy: 0 fractional worksSphingolipid Metabolism and Signaling: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksMitochondrial Function a…0Mitochondrial Function and Pathology: 0 fractional worksCircadian rhythm and melatonin: 0 fractional worksOvarian function and disorders: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional works
Molecular BiologyAgronomy and Crop ScienceBiochemistryEpidemiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Metabolomics and Mass Spectrometry Studies Molecular Biology 1 works
  2. 2 Reproductive Physiology in Livestock Agronomy and Crop Science 0 works
  3. 3 Lipid metabolism and biosynthesis Biochemistry 0 works
  4. 4 Autophagy in Disease and Therapy Epidemiology 0 works
  5. 5 Sphingolipid Metabolism and Signaling Molecular Biology 0 works
  6. 6 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  7. 7 Mitochondrial Function and Pathology Molecular Biology 0 works
  8. 8 Circadian rhythm and melatonin Endocrine and Autonomic Systems 0 works
  9. 9 Ovarian function and disorders Reproductive Medicine 0 works
  10. 10 Cancer, Lipids, and Metabolism Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available74.0%not open26.0%

World: 28% of research is openly available.

with international co-authors23.0%domestic only77.0%

World: 19% is written across borders.

How has LipidALL Technologies (China)'s research output changed?

Output in 2018–2022 was 771% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Changzhou

All research institutions in Changzhou

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.